VC-backed Indalo Therapeutics taps Jacks as president and CEO

Cambridge, Massachusetts-based Indalo Therapeutics, a biopharmaceutical company, has named Robert Jacks as president and CEO. He's the former co-founder, president and chief financial officer of Symbiomix Therapeutics. Indalo's backers include Atlas Venture and F-Prime Capital.